“

They informed us about the preliminary results, which they have gone to the press with. We await to see the final data analysis and the publication that's going to come out of it and certainly our committee will be considering these results as we go on, however, they are two distinct trials, with their own protocols, their own oversight committees and therefore we will continue for now and our committee will consider the data as it becomes available.